ATE474066T1 - Verfahren zum nachweis von pathogenen mittels molecular beacons - Google Patents

Verfahren zum nachweis von pathogenen mittels molecular beacons

Info

Publication number
ATE474066T1
ATE474066T1 AT06808556T AT06808556T ATE474066T1 AT E474066 T1 ATE474066 T1 AT E474066T1 AT 06808556 T AT06808556 T AT 06808556T AT 06808556 T AT06808556 T AT 06808556T AT E474066 T1 ATE474066 T1 AT E474066T1
Authority
AT
Austria
Prior art keywords
detecting pathogens
molecular beacons
probes
pathogens
detecting
Prior art date
Application number
AT06808556T
Other languages
English (en)
Inventor
Csaba Jeney
Tibor Takacs
Original Assignee
Genoid Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0523250A external-priority patent/GB0523250D0/en
Application filed by Genoid Kft filed Critical Genoid Kft
Application granted granted Critical
Publication of ATE474066T1 publication Critical patent/ATE474066T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/161—Modifications characterised by incorporating target specific and non-target specific sites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/30—Oligonucleotides characterised by their secondary structure
    • C12Q2525/301—Hairpin oligonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/10—Detection mode being characterised by the assay principle
    • C12Q2565/107—Alteration in the property of hybridised versus free label oligonucleotides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT06808556T 2005-11-15 2006-11-15 Verfahren zum nachweis von pathogenen mittels molecular beacons ATE474066T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73700605P 2005-11-15 2005-11-15
GB0523250A GB0523250D0 (en) 2005-11-15 2005-11-15 Method
PCT/GB2006/004266 WO2007057669A2 (en) 2005-11-15 2006-11-15 Method of detecting pathogens

Publications (1)

Publication Number Publication Date
ATE474066T1 true ATE474066T1 (de) 2010-07-15

Family

ID=37684956

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06808556T ATE474066T1 (de) 2005-11-15 2006-11-15 Verfahren zum nachweis von pathogenen mittels molecular beacons

Country Status (12)

Country Link
US (1) US7993881B2 (de)
EP (1) EP1844164B1 (de)
JP (1) JP2009515545A (de)
KR (1) KR20080084809A (de)
AT (1) ATE474066T1 (de)
AU (1) AU2006314297B2 (de)
CA (1) CA2629564C (de)
DE (1) DE602006015419D1 (de)
EA (1) EA014648B1 (de)
NO (1) NO20082657L (de)
PL (1) PL1844164T3 (de)
WO (1) WO2007057669A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642261B2 (en) * 2008-10-31 2014-02-04 Trovagene, Inc. Genetic marker for detection of human papillomavirus
CA2786473A1 (en) * 2010-01-08 2011-07-14 Qiagen Gaithersburg, Inc. Materials and methods for isothermal nucleic acid amplification
US8658397B2 (en) * 2010-02-16 2014-02-25 Becton, Dickinson And Company Assay for detecting closely-related serotypes of human papillomavirus (HPV)
WO2012135815A2 (en) * 2011-04-01 2012-10-04 Occam Biolabs, Inc. Methods and kits for detecting cell-free pathogen-specific nucleic acids
US20140212869A1 (en) * 2013-01-25 2014-07-31 Agilent Technologies, Inc. Nucleic Acid Proximity Assay Involving the Formation of a Three-way junction
US20170204481A1 (en) * 2014-12-22 2017-07-20 Enzo Biochem, Inc. Comprehensive and comparative flow cytometry-based methods for identifying the state of a biological system
GB201511470D0 (en) 2015-06-30 2015-08-12 Cellcall Kft HPV detection method
CA3017265C (en) * 2016-03-11 2022-08-16 F. Hoffmann-La Roche Ag Compositions and methods for detection of zika virus
KR102832926B1 (ko) * 2017-04-26 2025-07-10 에프. 호프만-라 로슈 아게 가용성 및 면역반응성 지카 바이러스 ns1 폴리펩티드
JPWO2020050350A1 (ja) * 2018-09-07 2021-08-30 株式会社ヘルスケアシステムズ ヒトパピローマウイルスの検出方法
JP7558167B2 (ja) 2018-12-03 2024-09-30 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム オリゴベンズアミド類似体およびがん処置におけるそれらの使用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2052413C (en) 1990-09-28 2004-07-13 Jeffrey L. Joseph Nucleotides sequences useful as type-specific probes, pcr primers and lcr probes for the amplifications and detection of human papilloma virus, and related kits and methods
FR2678284B1 (fr) * 1991-06-28 1993-10-08 Pasteur Institut Sequences d'adn derivees du genome du papillomavirus hpv42, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus et a la production de compositions immunogenes.
IL117591A0 (en) 1995-03-30 1996-07-23 Merck & Co Inc Synthetic DNA encoding human papillomavirus type 11 L1 protein
US20020102571A1 (en) * 1997-07-24 2002-08-01 Jane Theaker Use of 2'-O-methyl RNA as hybridisation probe
DE69806024T2 (de) * 1997-09-16 2003-02-13 Delft Diagnostic Laboratory B.V., Delft Erkennung und identifizierung von menschlichem papillomavirus durch pcr und typ-spezifischer reverser hybridisierung
US6037130A (en) * 1998-07-28 2000-03-14 The Public Health Institute Of The City Of New York, Inc. Wavelength-shifting probes and primers and their use in assays and kits
US6440706B1 (en) 1999-08-02 2002-08-27 Johns Hopkins University Digital amplification
WO2002100889A1 (fr) * 2001-06-08 2002-12-19 Kirin Beer Kabushiki Kaisha Nouvel epitope de l'antigene e7 du papillomavirus humain et lymphocytes t cd4 positifs actives par l'epitope
CA2451614C (en) 2001-06-25 2011-01-04 Georgia Tech Research Corporation Dual resonance energy transfer nucleic acid probes
US6898531B2 (en) * 2001-09-05 2005-05-24 Perlegen Sciences, Inc. Algorithms for selection of primer pairs
FR2832154B1 (fr) * 2001-11-09 2007-03-16 Centre Nat Rech Scient Oligonucleotides inhibiteurs et leur utilisation pour reprimer specifiquement un gene
ES2654909T3 (es) * 2002-01-07 2018-02-15 Pretect As Método para detectar ARNm del virus del papiloma humano
HUP0200981A3 (en) * 2002-03-14 2004-06-28 Genoid Kft Pcr reactions with hybridizing probes using primers with broad genotype-specificity for detection of human papilloma-viruses and typing amplificates by using specifically hybridizing oligonucleotides
US6713262B2 (en) * 2002-06-25 2004-03-30 Agilent Technologies, Inc. Methods and compositions for high throughput identification of protein/nucleic acid binding pairs
CN1860242B (zh) * 2003-08-01 2013-11-06 戴诺生物技术有限公司 自杂交多重靶核酸探针及其使用方法
WO2005033333A2 (en) * 2003-10-07 2005-04-14 Dako Denmark A/S Methods and compositions for the diagnosis of cancer

Also Published As

Publication number Publication date
EP1844164B1 (de) 2010-07-14
JP2009515545A (ja) 2009-04-16
US20090215030A1 (en) 2009-08-27
EA014648B1 (ru) 2010-12-30
AU2006314297B2 (en) 2012-10-18
AU2006314297A1 (en) 2007-05-24
EA200801315A1 (ru) 2008-10-30
PL1844164T3 (pl) 2010-12-31
WO2007057669A2 (en) 2007-05-24
WO2007057669A3 (en) 2007-08-02
EP1844164A2 (de) 2007-10-17
DE602006015419D1 (de) 2010-08-26
KR20080084809A (ko) 2008-09-19
US7993881B2 (en) 2011-08-09
CA2629564A1 (en) 2007-05-24
CA2629564C (en) 2014-04-22
NO20082657L (no) 2008-08-14

Similar Documents

Publication Publication Date Title
NO20082657L (no) Fremgangsmate for pavisning av patogener
MX2022014633A (es) Metodos para detectar norovirus.
DE602005016527D1 (de) Verfahren zur schnelldiagnose von zielen in menschlichen körperflüssigkeiten
WO2007133682A3 (en) 100% sequence identity detection methods for variable genomes
ATE485401T1 (de) Neue primer und sonden zum nachweis von parvovirus b19
EP1791956A4 (de) Oligonukleotid zum nachweis eines mikroorganismus, diagnostische kits und verfahren zum nachweis des mikroorganismus unter verwendung des oligonukleotids
ATE412905T1 (de) Diagnoseverfahren für lebersteatose unter verwendung biochemischer marker
NO20081127L (no) Vaksinering mot Dengue virusinfeksjon
EP2321430B8 (de) Verfahren zur bewertung des oralkarzinomrisikos bei menschen
DE60326748D1 (de) Verfahren zur identifizierung des brustkrebsrisikos
WO2005087951A3 (en) Reagents, methods and kits for use in deactivating nucleic acids
EA200401207A1 (ru) Способ обнаружения и определения типа папилломавируса человека с использованием амплификации-гибридизации
DE602005012481D1 (de) 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck
PL1895015T3 (pl) Sposób i zestaw do wykrywania gatunków bakteryjnych za pomocą analizy DNA
DE60328198D1 (de) Verfahren zur Vorhersage des Behandlungserfolgs mit Rivastigmine basierend auf einer Bestimmung des ApoE Genotyps eines Demenzkranken
EP1801578A4 (de) Vorrichtung und verfahren zur inspektion von mikrostrukturen
DE502004007244D1 (de) Verfahren zum spezifischen schnellnachweis getr nkesch dlicher mikroorganismen
ATE487799T1 (de) Multiplexanalyse von nukleinsäuren zur bestimmung von genotypen des humanen papillomavirus
WO2006022619A3 (en) Methods for identifying risk of type ii diabetes and treatments thereof
WO2002103043A3 (de) Verfahren zum spezifischen schnellnachweis bierschädlicher bakterien
CY1113242T1 (el) Μεθοδος και μεσα για ανιχνευση ανθρωπινων ιων θηλωματος
WO2009154357A3 (ko) 인유두종 바이러스 검출 방법 및 검출 키트
EA201001340A1 (ru) Улучшенный аналитический способ для определения латентного гепатита с, его применения и соответствующий диагностический набор
ATE420977T1 (de) Nachweisverfahren für ljungan-virus
ATE437957T1 (de) Schneller test auf peptidoglycanbasis zum nachweis der kontamination von blutplättchen mit bakterien

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1844164

Country of ref document: EP